Oncogenomics

Molecular Approaches to Cancer

Medium: Buch

ISBN: 978-0-471-22592-8

Verlag: Turner Publishing Company

Erscheinungstermin: 29.03.2004

151,50 € 141,59 € (zzgl. MwSt.)

In den Warenkorb

Lieferfrist: bis zu 10 Tage

Auf die Merkliste Drucken

Kundenservice

Telefon: +49 69 943 329 50
E-Mail: webshop@sack.de

» Kontaktformular

Bücher

Unsere Bücher sind versandkostenfrei erhältlich

Rücksendung

kostenlose Rücksendungen für Bücher

Noch Fragen?

Unser Kundenservice hilft gerne weiter

Beschreibung
Autoren/Hrsg.
Inhalt

This book aims to assemble the only available rigorous, yet broadly accessible introduction to this new and exciting field. Oncogenomics: Molecular Approaches to Cancer is approachable by basic scientists, practitioners, and other health professionals required to familiarize themselves with the tremendous impact of genomics and proteomics on cancer research. Clearly written chapters offer reviews of state of the art topics such as molecular classification, early detection, SNPs in cancer, data mining, tissue microarrays, protein and antibody arrays, and drug targets.

Produkteigenschaften

Artikelnummer: 9780471225928
Medium: Buch
ISBN: 978-0-471-22592-8
Verlag: Turner Publishing Company
Erscheinungstermin: 29.03.2004
Sprache(n): Englisch
Auflage: 1. Auflage 2004
Produktform: Gebunden
Gewicht: 903 g
Seiten: 400
Format (B x H x T): 181 x 264 x 24 mm
Ausgabetyp: Kein, Unbekannt

Themen

Herausgeber

Brenner, Charles

Duggan, David

Duggan, David J.

Contributors.

Preface.

Second I: Introduction.

1. At the Precarious Cusp of Oncogenomics (Charles Brenner).

Second II: Molecular Profiling in Cancer: DNA, RNA and Protein.

2. Genome-Wide Searches for Mutations in Human Cancer (Michael R. Stratton, P. Andrew Futreal, and Richard Wooster).

3. Molecular Cytogenetics: Increasing Resolution Using Array-Based CGH (Anne Kallioniemi).

4. SNPs and Functional Polymorphisms in Cancer (Penelope E. Bonnen and David L. Nelson).

5. Expression Profiling of Breast Cancer: From Molecular Portraits to Clinical Utility (Therese Sørlie, Anne-Lise Børresen-Dale, Per E. Lønning, Patrick O. Brown, and David Botstein).

6. Classifying Hereditary Cancers and Phenocopies of Hereditary Cancers Using Expression Arrays (Mary B. Daly, Alicia Parlanti, and David Duggan).

7. Linking Drugs and Genes: Pharmacogenomics, Pharmacoproteomics, Bioinformatics, and the NCI-60 (John N. Weinstein).

8. Tissue Microanalysis: Profiling Cancer Stages (Michael A. Tangrea and Michael R. Emmert-Buck).

9. Proteomic s in Bladder Cancer (Julio E. Celis, Irina Gromova, Fritz Rank and Pavel Gromov).

Second III: Model Systems.

10. Chemical and Genetic Methods to Validate Targets in Nonmammalian Organisms (Tia M. Maiolatesi and Charles Brenner).

11. Mouse Models of Cancer (Debrah M. Thompson, Louise van der Weyden, Patrick J. Biggs, Yeun-Jun Chung and Allan Bradley).

12. Genome-Wide Modifier Screens: How the Genetics of Cancer Penetrance May Shape the Future of Prevention and Treatment (Linda D. Siracusa, Karen A. Silverman, Revati Koratkar, Marina Markova and Arthur M. Buchberg).

Second IV: Molecularly Targeted Drugs.

13. Protein Kinases as Targets in Cancer Therapy: Validated and Emerging Approaches (Paul Nghiem, Yong-son Kim and Stuart L. Schreiber).

14. Ras Superfamily-Directed Compounds (George C. Prendergast).

15. Clinomics: Post-Genomic Cancer Care (Daniel D. Von Hoff, Haiyong Han, and David Bearss).

Part V: Conclusion).

16. Oncogenomics and the NCI Director's Vision for 2015 (Andrew C. von Eschenbach).

Index.

Site Breadcrumb